Logo image of FROG

JFROG LTD (FROG) Stock Fundamental Analysis

NASDAQ:FROG - Nasdaq - IL0011684185 - Common Stock - Currency: USD

42.9  +0.18 (+0.42%)

After market: 42.9 0 (0%)

Fundamental Rating

5

FROG gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. No worries on liquidiy or solvency for FROG as it has an excellent financial health rating, but there are worries on the profitability. FROG shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

FROG had positive earnings in the past year.
FROG had a positive operating cash flow in the past year.
FROG had negative earnings in each of the past 5 years.
Each year in the past 5 years FROG had a positive operating cash flow.
FROG Yearly Net Income VS EBIT VS OCF VS FCFFROG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

FROG has a Return On Assets (-6.13%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -8.95%, FROG is in line with its industry, outperforming 52.48% of the companies in the same industry.
Industry RankSector Rank
ROA -6.13%
ROE -8.95%
ROIC N/A
ROA(3y)-7.59%
ROA(5y)-6.33%
ROE(3y)-10.8%
ROE(5y)-8.83%
ROIC(3y)N/A
ROIC(5y)N/A
FROG Yearly ROA, ROE, ROICFROG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15

1.3 Margins

FROG has a better Gross Margin (77.06%) than 72.69% of its industry peers.
FROG's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for FROG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.15%
GM growth 5Y-0.97%
FROG Yearly Profit, Operating, Gross MarginsFROG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

More info and screens

8

2. Health

2.1 Basic Checks

FROG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for FROG has been increased compared to 1 year ago.
Compared to 5 years ago, FROG has more shares outstanding
There is no outstanding debt for FROG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
FROG Yearly Shares OutstandingFROG Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
FROG Yearly Total Debt VS Total AssetsFROG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 8.31 indicates that FROG is not in any danger for bankruptcy at the moment.
FROG has a Altman-Z score of 8.31. This is amongst the best in the industry. FROG outperforms 80.85% of its industry peers.
There is no outstanding debt for FROG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.31
ROIC/WACCN/A
WACC11.03%
FROG Yearly LT Debt VS Equity VS FCFFROG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

FROG has a Current Ratio of 2.04. This indicates that FROG is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.04, FROG is in the better half of the industry, outperforming 62.77% of the companies in the same industry.
A Quick Ratio of 2.04 indicates that FROG has no problem at all paying its short term obligations.
FROG has a better Quick ratio (2.04) than 63.12% of its industry peers.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 2.04
FROG Yearly Current Assets VS Current LiabilitesFROG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

8

3. Growth

3.1 Past

FROG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.11%, which is quite good.
Measured over the past years, FROG shows a very strong growth in Earnings Per Share. The EPS has been growing by 178.78% on average per year.
The Revenue has grown by 22.47% in the past year. This is a very strong growth!
FROG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 32.56% yearly.
EPS 1Y (TTM)13.11%
EPS 3Y178.78%
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)22.47%
Revenue growth 3Y27.51%
Revenue growth 5Y32.56%
Sales Q2Q%22.03%

3.2 Future

The Earnings Per Share is expected to grow by 17.28% on average over the next years. This is quite good.
Based on estimates for the next years, FROG will show a quite strong growth in Revenue. The Revenue will grow by 16.27% on average per year.
EPS Next Y8.73%
EPS Next 2Y12.39%
EPS Next 3Y17.28%
EPS Next 5YN/A
Revenue Next Year17.96%
Revenue Next 2Y16.64%
Revenue Next 3Y16.27%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
FROG Yearly Revenue VS EstimatesFROG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
FROG Yearly EPS VS EstimatesFROG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

FROG is valuated quite expensively with a Price/Earnings ratio of 62.17.
FROG's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.19, FROG is valued quite expensively.
A Price/Forward Earnings ratio of 52.25 indicates a quite expensive valuation of FROG.
The rest of the industry has a similar Price/Forward Earnings ratio as FROG.
FROG is valuated expensively when we compare the Price/Forward Earnings ratio to 22.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 62.17
Fwd PE 52.25
FROG Price Earnings VS Forward Price EarningsFROG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, FROG is valued a bit cheaper than the industry average as 62.77% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 45.6
EV/EBITDA N/A
FROG Per share dataFROG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as FROG's earnings are expected to grow with 17.28% in the coming years.
PEG (NY)7.12
PEG (5Y)N/A
EPS Next 2Y12.39%
EPS Next 3Y17.28%

More info and screens

0

5. Dividend

5.1 Amount

FROG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

JFROG LTD

NASDAQ:FROG (5/29/2025, 8:00:00 PM)

After market: 42.9 0 (0%)

42.9

+0.18 (+0.42%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners75.61%
Inst Owner Change3.71%
Ins Owners14.39%
Ins Owner Change-0.5%
Market Cap4.92B
Analysts81.43
Price Target44.64 (4.06%)
Short Float %3.84%
Short Ratio4.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)36.09%
Min EPS beat(2)33.1%
Max EPS beat(2)39.08%
EPS beat(4)4
Avg EPS beat(4)21.01%
Min EPS beat(4)2.88%
Max EPS beat(4)39.08%
EPS beat(8)8
Avg EPS beat(8)50.92%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.46%
Min Revenue beat(2)-0.34%
Max Revenue beat(2)1.25%
Revenue beat(4)1
Avg Revenue beat(4)-0.47%
Min Revenue beat(4)-2.47%
Max Revenue beat(4)1.25%
Revenue beat(8)2
Avg Revenue beat(8)-0.11%
Revenue beat(12)4
Avg Revenue beat(12)-0.06%
Revenue beat(16)5
Avg Revenue beat(16)-0.17%
PT rev (1m)-3.1%
PT rev (3m)-3.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.95%
EPS NY rev (1m)1.46%
EPS NY rev (3m)1.36%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.08%
Revenue NY rev (1m)0.38%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE 62.17
Fwd PE 52.25
P/S 11.47
P/FCF 45.6
P/OCF 44.31
P/B 6.35
P/tB 14.41
EV/EBITDA N/A
EPS(TTM)0.69
EY1.61%
EPS(NY)0.82
Fwd EY1.91%
FCF(TTM)0.94
FCFY2.19%
OCF(TTM)0.97
OCFY2.26%
SpS3.74
BVpS6.75
TBVpS2.98
PEG (NY)7.12
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.13%
ROE -8.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.06%
FCFM 25.15%
ROA(3y)-7.59%
ROA(5y)-6.33%
ROE(3y)-10.8%
ROE(5y)-8.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.15%
GM growth 5Y-0.97%
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 14.65%
Cap/Sales 0.73%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 2.04
Altman-Z 8.31
F-Score5
WACC11.03%
ROIC/WACCN/A
Cap/Depr(3y)19.73%
Cap/Depr(5y)42.11%
Cap/Sales(3y)0.98%
Cap/Sales(5y)1.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.11%
EPS 3Y178.78%
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y8.73%
EPS Next 2Y12.39%
EPS Next 3Y17.28%
EPS Next 5YN/A
Revenue 1Y (TTM)22.47%
Revenue growth 3Y27.51%
Revenue growth 5Y32.56%
Sales Q2Q%22.03%
Revenue Next Year17.96%
Revenue Next 2Y16.64%
Revenue Next 3Y16.27%
Revenue Next 5YN/A
EBIT growth 1Y-25.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year71.01%
EBIT Next 3Y39%
EBIT Next 5YN/A
FCF growth 1Y49.34%
FCF growth 3Y67.17%
FCF growth 5Y67.4%
OCF growth 1Y49.58%
OCF growth 3Y58.42%
OCF growth 5Y61.81%